Arvinas (ARVN) Invested Capital (2017 - 2026)
Arvinas (ARVN) recorded quarterly Invested Capital of $387.3 million in Q1 2026, down 10.86% quarter-over-quarter from $434.5 million in Q4 2025, and down 41.39% on a YoY basis from $660.8 million in Q1 2025.
Arvinas (ARVN) Invested Capital (2017 - 2026) Analysis & Trends
Arvinas' Invested Capital history runs 10 years deep, the most recent figure standing at $387.3 million for Q1 2026.
- In Q1 2026, Invested Capital fell 41.39% year-over-year to $387.3 million; the TTM figure through Mar 2026 stood at $387.3 million (down 41.39% YoY), while the FY2025 annual figure was $434.5 million, down 22.76% from the prior year.
- Invested Capital was $387.3 million for Q1 2026 at Arvinas, down from $434.5 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $724.3 million in Q1 2022 to a low of $387.3 million in Q1 2026.
- Historically, Invested Capital has averaged $570.5 million across 5 years, with a median of $586.8 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Invested Capital advanced 29.38% in 2024, then tumbled 41.39% in 2026.
- A 5-year view of Invested Capital shows it stood at $565.9 million in 2022, then grew by 16.81% to $661.0 million in 2023, then fell by 14.9% to $562.5 million in 2024, then slipped by 22.76% to $434.5 million in 2025, then decreased by 10.86% to $387.3 million in 2026.
- The last three Invested Capital figures came in at $387.3 million (Q1 2026), $434.5 million (Q4 2025), and $565.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 387.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 387.30 Mn |
| Dec 31, 2025 | 434.50 Mn |
| Sep 30, 2025 | 565.00 Mn |
| Jun 30, 2025 | 610.00 Mn |
| Mar 31, 2025 | 660.80 Mn |
| Dec 31, 2024 | 562.50 Mn |
| Sep 30, 2024 | 586.80 Mn |
| Jun 30, 2024 | 601.10 Mn |
| Mar 31, 2024 | 610.60 Mn |
| Dec 31, 2023 | 661.00 Mn |
| Sep 30, 2023 | 458.20 Mn |
| Jun 30, 2023 | 464.60 Mn |
| Mar 31, 2023 | 512.00 Mn |
| Dec 31, 2022 | 565.90 Mn |
| Sep 30, 2022 | 622.50 Mn |
| Jun 30, 2022 | 671.60 Mn |
| Mar 31, 2022 | 724.30 Mn |
| Dec 31, 2021 | 782.70 Mn |
| Sep 30, 2021 | 817.70 Mn |
| Jun 30, 2021 | 582.90 Mn |